Search Results 121-130 of 17190 for Hepatocyte
Participation eligibility · Adults with chronic liver disease due to NASH defined as macrovesicular steatosis involving > 5% of hepatocytes on a liver biopsy ...
Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...
As the first SPORE of its kind in the United States, the Mayo Clinic Hepatobiliary SPORE is devoted to improving outcomes in liver cancer and bile duct ...
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...
The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., conducts numerous clinical studies of hepatobiliary cancer, including its epidemiology ...
The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients ...
The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.